Offer - Urjas Oil for just ₹ 1 X
Voglipack M 500 Mg/0.3 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. Other than this, Voglipack M 500 Mg/0.3 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Voglipack M 500 Mg/0.3 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Voglipack M 500 Mg/0.3 Mg Tablet include Weakness, Headache, Nausea or vomiting. While these are the most often observed Voglipack M 500 Mg/0.3 Mg Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Voglipack M 500 Mg/0.3 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Voglipack M 500 Mg/0.3 Mg Tablet's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Voglipack M 500 Mg/0.3 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Voglipack M 500 Mg/0.3 Mg Tablet related warnings section.
Voglipack M 500 Mg/0.3 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetic Ketoacidosis are examples of such conditions.
Besides this, Voglipack M 500 Mg/0.3 Mg Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Voglipack M 500 Mg/0.3 Mg Tablet is considered not safe while driving, and is not addictive.
Voglipack M 500 Mg/0.3 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Voglipack M 500 Mg/0.3 Mg Tablet safe for pregnant women?
Voglipack M has many dangerous side effects in pregnant women. If you are pregnant, do not consume Voglipack M without medical advice.
Is the use of Voglipack M 500 Mg/0.3 Mg Tablet safe during breastfeeding?
Taking Voglipack M may lead to serious side effects if you are breastfeeding. Voglipack M should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Voglipack M 500 Mg/0.3 Mg Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Voglipack M. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Voglipack M 500 Mg/0.3 Mg Tablet on the Liver?
The liver can be affected by Voglipack M. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Voglipack M only after medical advice.
What is the effect of Voglipack M 500 Mg/0.3 Mg Tablet on the Heart?
Voglipack M is rarely harmful for the heart.
Voglipack M 500 Mg/0.3 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Voglipack M 500 Mg/0.3 Mg Tablet unless your doctor advises you to do so -
Is this Voglipack M 500 Mg/0.3 Mg Tablet habit forming or addictive?
Forming a habit of Voglipack M 500 Mg/0.3 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Voglipack M 500 Mg/0.3 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but take Voglipack M 500 Mg/0.3 Mg Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Voglipack M 500 Mg/0.3 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Voglipack M 500 Mg/0.3 Mg Tablet
There is no information on the effects of taking Voglipack M 500 Mg/0.3 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Voglipack M 500 Mg/0.3 Mg Tablet
It is difficult to say anything about the effect of Voglipack M 500 Mg/0.3 Mg Tablet and alcohol. No research has been done on this yet.
Yes, Voglipack M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that it causes hypoglycemia (low blood sugar) especially at night which leads to night sweats. You need to monitor your blood glucose level regularly and talk to your doctor as your dose may need to be adjusted.
Voglipack M is the brand name for voglibose. It is an oral antidiabetic drug that belongs to the class of medicine called alpha-glucosidase inhibitor. It is used in single or combined with other drugs to treat diabetes.
Yes, Voglipack M can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with voglibose. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia. It is best to consult your doctor if you feel any unwanted effects.
Yes, Voglipack M can be taken with gliclazide. No harmful interactions are reported between them. However, It is best to consult your doctor if you are experiencing any unpleasant side effects.
Voglipack M should be taken as long as needed or take it as directed by doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826